(Alliance News) - Optibiotix Health PLC on Tuesday said it began a clinical trial to determine the effect of its Wellbiome fibre complex on cardiac surgery outcomes. Read More
SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investigation of the events that led to the departure of Stuart Ashman as chief executive officer. Levett, who chairs the board's audit committee, will work with FRP Advisory, which the board has engaged to undertake a "forensic review". Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
(Alliance News) - ProBiotix Health PLC on Monday said it believes a fall in its share price may result from "mistaken assumptions" about events at SkinBioTherapeutics PLC. Read More
(Alliance News) - OptiBiotix Health PLC on Wednesday said it has received four large orders from Taiwan's Meelung Trading Co Ltd helping deliver a record start to financial 2026. Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it has received a first order from a "well-known" weight management company following an agreement announced in August. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
(Alliance News) - ProBiotix Health PLC on Monday reported an improved third quarter and said it is "comfortably on track" to meet its long-term aims. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
OptiBiotix Health PLC - York, England-based life sciences firm - Shares begin trading on the OTCQB Venture Market in the US at Thursday's market open under the symbol OPTBF. Notes this will not impact shares trading on the AIM Market in London. "OptiBiotix is building its consumer presence in the USA as shown by the recent launch of its appetite reducing SlimBiome in Hydroxycut, the [number] 1 selling weight loss supplement brand in the USA," says Chief Executive Officer Stephen O'Hara. "This follows on from launches earlier this year with new US partners such as NHT and Daily Nouri. As we increase our brand presence in the USA the board believe joining the OTCQB Market will help increase our visibility to the US investment community, broadening our shareholder base and improving liquidity." Read More
(Alliance News) - OptiBiotix Health PLC on Wednesday said it has signed a distribution agreement with a "well-known" and "established" weight management company, as it noted shifting consumer sentiment in the market. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it continues to grow its top line and improve margins, as investments open up a multi territory revenue stream. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More
OptiBiotix Health PLC - York-based life sciences firm - Says Finance Director Graham Myers will step down on November 30 and be replaced by David Blain, who will join as acting Finance Director on November 1. David Blain is currently financial director at Iksuda Therapeutics Ltd. Read More